Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: Dale Baker who wrote (6528)	5/25/1999 7:55:00 AM
From: JSB	Read Replies (1) \| Respond to of 118717

I can only imagine that the shorts are a bit concerned this morning. Stock is undervalued anyway and a pretty fair investment, especially in light of the rebound of the IT sector. The meeting was canceled yesterday afternoon and the only scenario that makes any sense is the receipt of an offer.

To: Dale Baker who wrote (6528)	5/25/1999 8:21:00 AM
From: JSB	Respond to of 118717

The site for the Dtag research is apnet.com it has to be viewed in the evenings since we are not registered. the site for the toxicity studies is bioresco.ch

To: Dale Baker who wrote (6528)	5/25/1999 8:25:00 AM
From: JustInTime	Read Replies (2) \| Respond to of 118717

>>What could this be apart from a buyout? (ITIG) It could be some truly horrible news as well I suppose, just to play devils advocate, but with the low PE, a string af new contract annoucements, increasing volume and price I have a hard time believing that some major disaster is going to be announced, these things always leak out to at least someone, and if someone knew, the price would have tanked. I have my fingers crossed, and really hope there is good news coming, not bad news. Hopefully we will learn more today...if they cancelled the shareholders meeting, on very short notice I might add, they had better get some annoucement out very soon....